SCHEDULE 13G/A: Major Shareholder Juan Jose Chacon Quiros Discloses 5.2% Stake in Establishment Labs Holdings Inc.

Juan Jose Chacon Quiros has reported beneficial ownership of 5.2% of Establishment Labs Holdings Inc.'s common shares as of December 31, 2024, through direct holdings, stock options, and an LLC.

Summary

• Juan Jose Chacon Quiros beneficially owns a total of 1,450,184 common shares of Establishment Labs Holdings Inc. as of December 31, 2024.
• This ownership represents 5.2% of the company's common shares outstanding.
• The calculation of the ownership percentage is based on 27,997,883 common shares outstanding as of November 11, 2024, as reported in the Issuer's Form 10-Q.
• Mr. Quiros's beneficial ownership comprises 186,350 directly held common shares, 135,570 common shares acquirable within 60 days through stock option exercise, and 1,128,264 common shares held by Sariel LLC, an entity over which Mr. Quiros has voting and dispositive power.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would significantly alter sentiment regarding the company's operational or financial performance.

Positives

• The filing indicates a significant and stable ownership stake by a key individual, Juan Jose Chacon Quiros, suggesting continued alignment with the company's long-term interests.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• Juan Jose Chacon Quiros's beneficial ownership includes 1,128,264 common shares held of record by Sariel LLC, an entity where Mr. Quiros is a shareholder and holds voting and dispositive power.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant insider's ownership stake, which can influence investor confidence.

Key Dates

Keywords

Establishment Labs Holdings Inc., Juan Jose Chacon Quiros, Schedule 13G, beneficial ownership, common shares, equity stake, SEC filing, investor disclosure, corporate governance